Table 1.
Sample characteristics.
Table 2.
Annual ADHD-related visit rates by age, sex, income quintile, and rurality.
Fig 1.
Expected and observed trends in ADHD-related visit rates during the COVID-19 pandemic*.
*The pre-pandemic data (2017–2019) are used to estimate the expected rate during the pandemic years 2020–2021 (with 95% CI). Data for Fig 1 are found in the Supporting information file, see S2A Table in S2 Table.
Table 3.
Annual prevalence of patients with one or more ADHD-related visits by age, sex, income quintile, and rurality.
Fig 2.
Expected and observed trends in ADHD-related visit prevalence during the COVID-19 pandemic*.
*The pre-pandemic data (2017–2019) are used to estimate the expected rate during the pandemic years 2020–2021 (with 95% CI). Data for Fig 2 are found in the Supporting information file, see S2B Table in S2 Table.
Table 4.
Annual prevalence of patients with one or more prescriptions for an ADHD-related medication by age, sex, income quintile, and rurality.
Fig 3.
Expected and observed trends in ADHD prescription prevalence during the COVID-19 pandemic*.
*The pre-pandemic data (2017–2019) are used to estimate the expected rate during the pandemic years 2020–2021 (with 95% CI). Data for Fig 3 are found in the Supporting information file, see S2C Table in S2 Table.